Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients
Clinical trial NCT04164238 · UNKNOWN
Trial details
- NCT number
- NCT04164238
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-07
- Primary completion
- 2020-11-07
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.